Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics

scientific article published on April 2016

Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1042/CS20150153
P698PubMed publication ID26957644

P50authorKay L DoubleQ57548330
P2093author name stringJulian F B Mercer
Katherine M Davies
Nicholas Chen
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectParkinson's diseaseQ11085
P304page(s)565-574
P577publication date2016-04-01
P1433published inClinical ScienceQ372419
P1476titleCopper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics
P478volume130

Reverse relations

cites work (P2860)
Q92703211Case of Early-Onset Parkinson's Disease in a Heterozygous Mutation Carrier of the ATP7B Gene
Q37209945Coordination Environment of Cu(II) Ions Bound to N-Terminal Peptide Fragments of Angiogenin Protein.
Q89511106Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant?
Q47408660Copper and Zinc Homeostasis: Lessons from Drosophila melanogaster
Q59600524Copper chaperone blocks amyloid formation via ternary complex
Q51650805Copper comes of age in Melbourne.
Q90310172Copper induce zebrafish retinal developmental defects via triggering stresses and apoptosis
Q57801718Copper signalling: causes and consequences
Q47611418Dexamethasone Inhibits Copper-Induced Alpha-Synuclein Aggregation by a Metallothionein-Dependent Mechanism
Q90319955Differential effects of Cu2+ and Fe3+ ions on in vitro amyloid formation of biologically-relevant α-synuclein variants
Q52714245Emerging Disease-Modifying Strategies Targeting α-Synuclein for the Treatment of Parkinson Disease.
Q92623198Folding of copper proteins: role of the metal?
Q93133706Lentinula edodes as a Source of Bioelements Released into Artificial Digestive Juices and Potential Anti-inflammatory Material
Q64771830Localization of the Locus Coeruleus in the Mouse Brain
Q93083418Medicinal chemistry of acridine and its analogues
Q92028537Metal Chelation Therapy and Parkinson's Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs
Q37737068Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies.
Q51735978Multimodal LA-ICP-MS and nanoSIMS imaging enables copper mapping within photoreceptor megamitochondria in a zebrafish model of Menkes disease.
Q46309593Occupational Metal Exposure and Parkinsonism
Q40406670Outlining a Population "at Risk" of Parkinson's Disease: Evidence from a Case-Control Study.
Q64998488Pentiptycene-Derived Fluorescence Turn-Off Polymer Chemosensor for Copper(II) Cation with High Selectivity and Sensitivity.
Q48514121Rare Disease Mechanisms Identified by Genealogical Proteomics of Copper Homeostasis Mutant Pedigrees
Q95299201Rare Genetic Diseases: Nature's Experiments on Human Development
Q58614416Redox nanoparticles: synthesis, properties and perspectives of use for treatment of neurodegenerative diseases
Q48004140Studies of copper trafficking in a mouse model of Alzheimer's disease by positron emission tomography: comparison of 64Cu acetate and 64CuGTSM.
Q47614352Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain.
Q64243678Switching on Endogenous Metal Binding Proteins in Parkinson's Disease
Q90423306Targeting of copper-trafficking chaperones causes gene-specific systemic pathology in Drosophila melanogaster: prospective expansion of mutational landscapes that regulate tumor resistance to cisplatin
Q57493310The Influence of Heavy Metals and Trace Elements on Comatose Patients with Severe Traumatic Brain Injury in the First Week of Admission
Q39235096The emerging role of retromer in neuroprotection
Q33591202The interactome of the copper transporter ATP7A belongs to a network of neurodevelopmental and neurodegeneration factors.

Search more.